Extracellular Vesicle Heterogeneity and Therapeutic Potential—Scott Bonner—Oxford University
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 19 February 2020
⏱️ 38 minutes
🧾️ Download transcript
Summary
As a Ph.D. student at Oxford University, Scott Bonner's work aims to examine extracellular vesicle (EV) heterogeneity and what it might teach us about the therapeutic function of EVs.
He explains the following:
- How many EVs one cell can produce, and why it is difficult albeit possible to examine singular vesicle phenotypes
- How significant a role EVs play in communication between cells, and what other methods cells use for intercellular communication
- How certain EV purification methods might disrupt the integrity of an EV itself by altering its shape and/or therapeutic potential
Extracellular vesicles hold great potential as a therapeutic delivery platform and might provide therapy for everything from broken bones to complicated disease processes like cancer. In addition, they could be used to package and deliver drugs to very specific regions in the body without running the risk of being hindered by the immune system, thereby providing greater efficacy than what's currently seen with drugs administered conventionally.
Scott Bonner shares what compelled him to pursue a career in EV-based research, and how his interest was jump-started by his time as a research assistant for Evox Therapeutics, a company that is now well-known in the field of exosome and EV-based therapeutics.
Bonner's current research aims to better understand vesicle heterogeneity and involves the creation of single-cell clones of a particular cell type that are grown separate from all other cells and cell types. Over time, the expectation is that the phenotypes of these cells will drift apart—even if only slightly—and that this could provide insight into how differences in EV phenotype affect EV function.
Ultimately, the findings could provide the industry with valuable information about the physical characteristics of EVs that hold the potential to therapeutically affect specific disease processes, such as breast cancer.
A number of interesting topics are explored, so tune in, and email your questions or comments to scott.bonner@wolfson.ox.ac.uk.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Forget frequently asked questions. |
| 0:02.0 | Common sense, common knowledge, or Google. |
| 0:05.0 | How about advice from a real genius? |
| 0:07.0 | 95% of people in any profession are good enough to be qualified and licensed. |
| 0:11.0 | 5% go above and beyond. They become very good at what they do, but only 0.1% are real Jesus. |
| 0:18.0 | Richard Jacobs has made it his life's mission to find them for you. He hunts down and interviews geniuses in every field, sleep science, |
| 0:25.7 | cancer, stem cells, ketogenic diets, and more. Here come the geniuses. This is the Finding Genius |
| 0:32.1 | podcast that Richard Jacobs. This is the Finding Genius Podcast. |
| 0:33.0 | That is Richard Jacobs. |
| 0:35.0 | Hello, this is Richard Jacobs with The Future Tech and Finding Genius |
| 0:42.0 | Podcast Series. |
| 0:43.0 | I've got Scott Bonner, he's a PhD student at Oxford University over in England. |
| 0:48.0 | We're going to be talking about extra-silator bicycles, one of my new favorite topics. |
| 0:52.0 | So Scott, thanks for coming. |
| 0:54.0 | Hi Richard, thanks. Thanks for having me on. |
| 0:56.0 | Yeah, it seems like there's a lot of attention about EVs lately. |
| 1:00.0 | So what attracted you to study them and what are you working on it specifically? |
| 1:04.7 | So what attracted me to Exrasoevicals was just the diverse array of possibilities there are surrounding |
| 1:19.0 | vehicles in terms of them as a therapeutic delivery platform and how they can have potential to effect and sort of provide a therapy for almost anything you can you can really think of from |
| 1:37.3 | really basic things like like broken bones through to really complex sort of processes like cancer and being able to safely deliver |
| 1:47.4 | potentially a drug that's already on the market to a specific site within the human body without it being moped up by the immune system allows us to sort of achieve a much higher efficacy than what you might be able to achieve than just using |
| 2:06.8 | that drug alone. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.